MYL - Mylan Inc. (NASDAQ Stock)

[BadThad]

Another possible bounce play. Really, the drop is unwarranted as nothing been proved. MYL basically says it's BS, do some DD. This is a good pharma company.

Mylan Inc. (Mylan) and its subsidiaries comprise a global pharmaceutical company that develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients (API). As of May 5, 2009, the Company held a 71.2% interest in Matrix Laboratories Limited (Matrix). Through Matrix, it manufactures and supplies API for its own products and pipeline, as well as for third parties. Mylan has three segments: the Generics Segment, the Matrix Segment and the Specialty Segment. Mylan markets more than 570 products to consumers in more than 140 countries. Mylan’s products cover an array of therapeutic categories, and offer a range of dosage forms and delivery systems, including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products. On June 2, 2008, the Company acquired Merck KGaA’s Central & Eastern Europe (CEE) generics businesses.

Mylan Inc. - Google Finance

Current Stock Price: $12.11 (down 12.56%)

[BadThad]

Man, busy this moring and missed the bounce, $13.12 right now. See, I know this drug biz!

Mylan rebounds on FDA thumbs up
9:52a ET July 28, 2009 (MarketWatch)
BOSTON (MarketWatch) -- Shares of Mylan Inc. were on the rebound early Tuesday after the generic drugmaker said inspectors from the Food and Drug Administration have found no deficiencies at its Morgantown, W. Va., manufacturing plant. Mylan shares fell over 10% on Monday on a published report in the Pittsburgh Post Gazette that questioned the company's quality control practices at the facility. Mylan said it alerted the FDA to the story as a courtesy, and that the agency sent inspectors to tour the plant on Monday. Shares of Mylan were up 9% at $13.16 in morning trading.

[greencat]

MYL breking over a top and looking to complete the cup pattern at $23.50

Shares Outstanding5: 309.73M
Float: 287.30M
% Held by Insiders6: 2.32%
% Held by Institutions6: 109.20%
Shares Short (as of Nov 30, 2010)3: 33.78M
Short Ratio (as of Nov 30, 2010)3: 3.50
Revenue (ttm): 5.37B
Total Debt (mrq): 5.41B

MYL Chart